Artelo Biosciences (ARTL) Intangibles (2019 - 2025)
Artelo Biosciences (ARTL) posted quarterly Intangibles of $2.0 million for Q4 2025, little changed year-over-year from $2.0 million in Q4 2024, and little changed quarter-over-quarter from $2.0 million in Q3 2025.
Artelo Biosciences (ARTL) Intangibles (2019 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Intangibles for 7 consecutive years, with $2.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Intangibles changed 0.0% year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at $2.0 million (changed 0.0% YoY), while the FY2025 annual figure was $2.0 million, changed 0.0% from the prior year.
- Intangibles steadied at $2.0 million in Q4 2025 per ARTL's latest filing, from $2.0 million in the prior quarter.
- Across five years, Intangibles topped out at $2.0 million in Q1 2021 and bottomed at $2.0 million in Q3 2021.
- Historically, Intangibles has averaged $2.0 million across 5 years, with a median of $2.0 million in 2021.
- On a YoY basis, Intangibles climbed as much as 0.0% in 2021 and fell as far as 0.02% in 2021.
- Artelo Biosciences' Intangibles stood at $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
- Business Quant data shows ARTL's Intangibles at $2.0 million in Q4 2025, $2.0 million in Q3 2025, and $2.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | 2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.04 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 2.04 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 2.04 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | 2.04 Mn |
| Mar 31, 2023 | 2.04 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 2.04 Mn |
| Mar 31, 2022 | 2.04 Mn |
| Nov 30, 2021 | 2.04 Mn |
| Aug 31, 2021 | 2.04 Mn |
| May 31, 2021 | 2.04 Mn |
| Feb 28, 2021 | 2.04 Mn |